René Bernards
2022
In 2022, René Bernards earned a total compensation of $133.9K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Other | $133,873 |
|---|---|
| Total | $133,873 |
Bernards received $133.9K in other compensation, accounting for 100% of the total pay in 2022.
Rankings
In 2022, René Bernards' compensation ranked 5,537th out of 5,753 executives tracked by ExecPay. In other words, Bernards earned more than 3.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,537 out of 5,753 | 4th |
Division Manufacturing | 3,025 out of 3,133 | 3rd |
Major group Chemicals And Allied Products | 1,382 out of 1,419 | 3rd |
Industry group Drugs | 1,289 out of 1,320 | 2nd |
Industry Pharmaceutical Preparations | 939 out of 966 | 3rd |
Source: SEC filing on November 4, 2024.
Bernards' colleagues
We found six more compensation records of executives who worked with René Bernards at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS